Pharmacy professionals' knowledge, attitude and practice towards doping in sports: A Cross-sectional study in Ethiopia.
Attitude
Doping
Knowledge
Pharmacy professionals
Practice
World anti-doping agency
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
22
12
2022
revised:
14
09
2023
accepted:
18
10
2023
medline:
15
11
2023
pubmed:
15
11
2023
entrez:
15
11
2023
Statut:
epublish
Résumé
Doping is appearing as a major problem in Ethiopia, a country decorated with medium and long-distance runners. To protect athletes from doping, pharmacists can be the first port of call for advising athletes on drug treatment. Hence, to fuel the anti-doping movement, it is crucial to explore the knowledge, attitude, and practice of community pharmacy professionals. Therefore, this study aimed to assess the community pharmacy professionals' knowledge, attitude, and practices towards doping in sports in Addis Ababa, Ethiopia. A cross-sectional survey, involving 336 study participants, was conducted in selected community pharmacies of Addis Ababa, Ethiopia from April to May 2018. Of 336 study participants, most of them knew the word "doping" and out of these, 51.9 % of them wrote the definition of doping correctly. Most respondents classified narcotics, hormone modulators, growth factors, and β-2 agonists correctly. Almost one-third of the professionals agreed that they have adequate information about doping and that doping is a public health problem. Among the participants, only 33.4 % were confronted with "suspicious of doping substance" without a prescription over the last 12 months. Although most pharmacy professionals lack doping-specific knowledge and adequate training required to be operative in doping prevention, most of them perceive doping as a public health problem although the curriculum does not have good coverage about doping.
Sections du résumé
Background
UNASSIGNED
Doping is appearing as a major problem in Ethiopia, a country decorated with medium and long-distance runners. To protect athletes from doping, pharmacists can be the first port of call for advising athletes on drug treatment. Hence, to fuel the anti-doping movement, it is crucial to explore the knowledge, attitude, and practice of community pharmacy professionals. Therefore, this study aimed to assess the community pharmacy professionals' knowledge, attitude, and practices towards doping in sports in Addis Ababa, Ethiopia.
Materials and methods
UNASSIGNED
A cross-sectional survey, involving 336 study participants, was conducted in selected community pharmacies of Addis Ababa, Ethiopia from April to May 2018.
Results
UNASSIGNED
Of 336 study participants, most of them knew the word "doping" and out of these, 51.9 % of them wrote the definition of doping correctly. Most respondents classified narcotics, hormone modulators, growth factors, and β-2 agonists correctly. Almost one-third of the professionals agreed that they have adequate information about doping and that doping is a public health problem. Among the participants, only 33.4 % were confronted with "suspicious of doping substance" without a prescription over the last 12 months.
Conclusions
UNASSIGNED
Although most pharmacy professionals lack doping-specific knowledge and adequate training required to be operative in doping prevention, most of them perceive doping as a public health problem although the curriculum does not have good coverage about doping.
Identifiants
pubmed: 37964848
doi: 10.1016/j.heliyon.2023.e21207
pii: S2405-8440(23)08415-3
pmc: PMC10641145
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e21207Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
BMC Res Notes. 2017 Aug 11;10(1):396
pubmed: 28800770
J Res Pharm Pract. 2017 Jul-Sep;6(3):166-172
pubmed: 29026842
J Endocrinol. 2001 Jul;170(1):13-25
pubmed: 11431133
Yakugaku Zasshi. 2011;131(12):1761-4
pubmed: 22129874
Biol Pharm Bull. 2013;36(2):305-10
pubmed: 23370359
Am J Pharm Educ. 2015 Oct 25;79(8):119
pubmed: 26689844
Drug Alcohol Rev. 2008 Mar;27(2):123-9
pubmed: 18264871
Eur J Cardiovasc Prev Rehabil. 2007 Aug;14(4):487-94
pubmed: 17667636
Eur J Epidemiol. 2006;21(4):307-13
pubmed: 16685582
Growth Horm IGF Res. 2009 Aug;19(4):320-6
pubmed: 19467612
Fundam Clin Pharmacol. 2011 Oct;25(5):535-63
pubmed: 21039821
Ir Med J. 2009 Jan;102(1):8-10
pubmed: 19284009
Am J Pharm Educ. 2008 Feb 15;72(1):19
pubmed: 18322580
Int J Drug Policy. 2011 May;22(3):198-202
pubmed: 21481579
Scand J Med Sci Sports. 2012 Apr;22(2):293-301
pubmed: 20973831
Sports Med. 2000 Jun;29(6):397-405
pubmed: 10870866